Please login to the form below

Listeria monocytogenes

This page shows the latest Listeria monocytogenes news and features for those working in and with pharma, biotech and healthcare.

Listeria monocytogenes (Lm) technology to create a tailored cancer treatment.

Listeria-based vaccine could halt breast cancer

The vaccine was developed from investigations into the Listeria monocytogenes bacterium which grows in milk, cheese and other dairy products. ... Listeria blocks the immune system's response when it gains access to the body, helping it to spread.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Pharma deals during October 2014

on Aduro's novel LADD [live-attenuated double-deleted Listeria monocytogenes strains that have been engineered to induce an innate immune response] immunotherapy platform.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Senior Account Director development role to Business Director, H...: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Add my company

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Redefining communications excellence: How to be heard in today’s multichannel, multistakeholder, multimedia world...
AstraZeneca: building a new ‘open innovation’ pharma company: The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
In conversation with Pfizer’s Erik Nordkamp: Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...